Sunteți pe pagina 1din 6

DAFTAR PUSTAKA 1. Lambrou NC, Buller JL, Thompson JR, et al.

prevalence of perioperative complications among women undergoing reconstructive pelvic surgery. Am J Obstet Gynecol 2000;183 (6):1355-1358. 2. Dicker Rc, Greenspan JR, Strauss LT, et al. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States: the colaborative review of sterilization. Am J Obstet Gynecol 1982;144:841-848. 3. Kingsnorth AN, Skandalakis PN, Colborn GL, et al. Embryology, anatomy, and surgical applications of the preperitoneal space. Surg Clin North AM 2000;80(1): 1-24. 4. Shull BL. How I do the abdominal paravaginal repair? J pelvic Surg 1995;1:43-49. 5. Stanton SL. Surgery of urinary incontinence. Clin Obstet Gynecol 1978;5:83-108. 6. Swartz WH, Tanaree P. Suction drainage as an alternative to prophylactic antibiotics for hyterectomy. Obstet Gynecol 1975;45:305-310. 7. Swartz WH, Tanaree P. T-Tube suction drainage and/or prophylactic antibiotics: a randomized study of 451 hyterectomies. Obstet Gynecol 1976;69:879-882. 8. Soper DE, Yarwood RL. Single-dose antibiotic prophylaxis in women undergoing vaginal hysterectomy. Obstet Gynecol 1987;69:879-882. 9. Elser DM, Tomezsko JE. A randomized prospektive comparison of changing gloves during abdomino-vaginal pelvic reconstructive surgery [Abstract]. Society of Gynecologic Surgeons, 27th Scientific Meeting, Lake Buena Vista, Fl. Mar 5-7, 2001. 10. Beck RP, McCormick S, Nordstrom L. The fascia lata sling procedure for treating recurrent genuine stress incontinence of urine. Obstet Gynecol 1988;72:699-703. 11. Bent AE,Ostergard DR, Zwick-Zaffulo M. Tissue reaction to expanded polytetrafluoroethylene suburethral sling for urinary incontinence:clinical and histological study. Am J Obstet Gynecol 1993;169:1198-1204.

12. Golomb J, Groutz A, Mor Y, et al. Management of urethral erosion caused by a pubovaginal fascial sling. Urology 2001;57:159-160. 13. Horbach NS, Blanco JS, Ostergard DR, et al. A suburethral sling procedure with polytetrafluoroethylene for the treatmen of genuine stress incontinence in patients with low urethral closure pressure. Obstet Gynecol 1988;71:648-652. 14. Morgan JE, Farrow GA, Stewart FE. The Marlex sling operation for the treatment of recurrent stress urinary incontinence: a 16-year review. Am J Obstet Gynecol 1985;201:705-711. 15. Falconer C, Sodenberg M, Blomgren B, et al. Influence of different sling materials on connective tissue metabolism in stress urinary incontinent women. Int Urogynecol J 2001;12 [Suppl 2]:S19-S23. 16. Brown GL, Richardson JE, Malangoni MA, et al. Comparison of prosthetic materials and abdominal wall reconstruction in the presence of contamination and infection. Ann Surg 1985;201:705-711. 17. Clemens JQ, DeLancey JOL, Faerber GJ, et al. Urinary tract erosions after synthetic pubovaginal slings: diagnosis and management strategy. Urology 2000;56:589-594. 18. Chai TC, Sklar GN. Use of the flexible cystoscope as a vaginoscope to aid in the diagnosis of artificial sling erosion. Urology 1999;53:617-618. 19. Myers DL, LaSala CA. Conservative surgical management of Mersilene mesh suburethral sling erosion. Am J Obstet Gynecol 1998;179:14241428. 20. Gamble JG, Simmons SC, Freedman M. The symphisis pubis: anatomic and pathologic considerations. Clin Orthop 1986;203:261-272. 21. Mainprize TC, Drutz HP. The Marshall-Marchetti-Kranz procedure: a critical review. Obstet Gynecol Surv 1988;43:724-729. 22. Merimsky E, Canetti R, Firstater M. Osteitis pubis:treatment by heparinization. Br J Urol 1981;53:154-156. 23. Winters JC, Scarpero HM, Appell RA. Use of bone anchors in female urology. Urology 2000;56[6 Suppl 1]:15-22.

24. Fitzgerald MP, Gitelis S, Brubaker L. Pubic osteomyelitis and granuloma after bone anchor placement. Int Urogynecol J Pelvic Floor Dysfunct 1999;10(5):346-348. 25. Franks ME, Lavelle JP, Yokoyama T, et al. Metastatic osteomyelitis after pubovaginal sling using bone anchors. Urology 2000;56:330-331. 26. Warren JW. Catheter-associated urinary tract infections. Infect Dis Clin North Am 1987;1:823-854. 27. Khanna OP. Nonsurgical therapeutic modalities. In: Krane RJ, Siroky MB, eds. Clinical neuro-urology. Boston: Little Brown, 1979:159-196. 28. Sethia KK, Selkon JB, Turner CM, et al. Prospective randomized controlled trial of urethral versus suprapubic catheterization. Br J Surg 1987;74:624-625. 29. Schiotz HA, Malme PA, Tanbo TG. Urinary tract infections and asymptomatic bacteriuria after vaginal plastic surgery: a comparison of suprapubic and transurethral catheters. Acta Obstet Gynecol Scand 1989;68:453-455. 30. Theofrastous J, Cobb D, VanDyke A, et al. A randomized trial of suprapubic vs. transurethral catheter drainage following Burch uretthropexy [Abstract]. The Society Of Gynecologic Surgeons 26 th Scientific Meeting, New Orleans, LA, February 28 to March 1, 2000. 31. Speights SE, Moore RD, Miklos JR. Frequency of lower urinary tract injury at laparoscopic Burch and paravaginal repair. J Am Assoc Gynecol Laparosc 2000;7:515-518. 32. Harris RL, Cundiff GW, Theofrastous JP, et al. The value of intraoperative cyctoscopy in urogynecologic and reconstructive pelvic surgery. Am J Obstet Gynecol 1997;177:1367-1371. 33. Lee RA, Symmonds RE, Goldstein RA. Surgical complications and results of modified Marshall-Marchetti-Krantz procedure for urinary incontinence. Obstet Gynecol 1979;53:447-450. 34. Timmons MC, Addiso WA. Suprapubic telescopy: extraperitoneal intraoperative technique demonstrate ureteral patency. Obstet Gynecol 1990;75:137-139.

35. Petit PD. Double-J ureteral catheters in gynecologic surgery. Obstet Gynecol 1989;75:536-540. 36. Podratz KC, Angerman NS, Symmons RE. Complications of ureteral sugery in the nonradiated patient. In: Delgada G, Smith JP, eds. Managementt of complications in gynecologic oncology. New York: Wiley, 1982:113-149. 37. Maxted W. Complications of bladder surgery and cystoscopy. In: Delgada G, Smith JP, eds. Managementt of complications in gynecologic oncology. New York: Wiley, 1982:151-162. 38. Hertogs K, Stanton SL. Mechanism of urinary continence after colposuspension: barrier studies. Br J Obstet Gynaecol 1985;92:11841188. 39. Bump RC, Fant JA, Hurt WG. Dynamic urethral presure profilometry presure transmission ratio determinations after continence surgery: understanding the mechanism of success, failure, adn complications. Obstet Gynecol 1988;72:870-877. 40. Stanton SL, Cardozo LD, Keer-Wilson R, Treatment of delayed onset of spontaneous voiding after surgery for incontinence. Urology 1979;13:494-496. 41. Carr LK, Webster GD. Voiding dysfunctions following incontinence surgery: diagnosis and treatment with retopubic or vaginal urethrolysis. J Urol 1997;157:821-823. 42. Nitti VW, Raz S. Obstruction following anti-incontinence procedures: diagnosis and treatment with transvaginal urethrolysis. J Urol 1994;152:93-98. 43. Webster GD, Kreder KJ. Voiding dysfunction following cystourethropexy: its evaluation management. J Urol 1990;144:670. 44. Zimmern PE, Hadley HR, Leach GE, et al. Female urethral obtruction after Marshall-Marchetti-Krantz operation. J Urol 1987;138:517. 45. Petrou SP, Brown JA, Blaivas JG. Sprameatal transvaginal uretrholysis. J Urol 1999;161:1268-1271.

46. McLennan MT, Bent AE. Sling incision with associated vaginal wall interposition for obstructed voiding secondary to suburethral sling procedure. In Urogynecol J Pelvic Floor Dysfunct 1997;8:168-172. 47. Goldman HB,Rackley RR, Appell RA. The efficacy of urethrolysis without re-suspension for iatrogenic uretrhal obtruction. J Urol 1999;161:196-198. 48. Foster HE, McGuire EJ, Management of urethral obstruction with transvaginal urethrolysis. J Urol 1993;150:1448-1451. 49. Cardozo LD, Stanton EL, Williams JE. Detrusor instanbility following surgery genuine stress incontinence. Br J Urol 1979;51:204-207. 50. Sand PK, Bowen LW, Ostergard DR, et al. The effect of retropubic urethropexy on detrusor stability. Obstet Gynecol 1988;71:818-822. 51. Glowacki CA, Wall LL. Bone anchors in urogynecology. Clin Obstet Gynecol 2000;43:659-669.

BACAAN YANG DIANJURKAN


Awad SA, Flood HD, Acker KL. The significance of prior anti-incontinence surgery in women who present with urinary incontinence. J Urol 1988;140:514517. Crane JK, bump RC, drug therapy for urologic disorders. In: Rayburn WF, Zuspan FP, eds. Drug therapy and obstetrics and gynecolgi, 2nd ed. Norwalk, CT: Appleton-Century-Crofs,1986:419-433. Jaschevatzky OE, Anerman S, Shalit A., et al. Prostaglandin F2a for prevention of urinary retention after vaginal hysterectomy. Obstet Gynecol 1985;66:244-247. McLennan MT, Melick CF, Bent AE. Clinical and urodynamic predictors of delayed voiding after fascia lata suburuthral sling. Obstet Gynecol 1998;92:608612. Rackley RR, Abdelmalak JB, Tcetgen MB, et al. Tension free vaginal tape and percutaneous vaginal tape sling procedures. Tech Urol 2001;7:90-100. Romanzi LJ, Blaivas JG. Protracted urinary retension necessitating urethrolysis following tension-free vaginal tape surgery. J Urol 2000;164:2022-2023.

Tammela T, Kontturi M, Kaar K, et al. Intravesical prostaglandin F2 for promoting bladder emptying after surgery for female stress incontinence. Br J Urol 1987;60:43-46. Wang AC, Lo TS. Tension-free vaginal tape. A minimally invasive solution to stress urinary incontinence in women. J Reprod Med 1998;43:49